Last reviewed · How we verify

NCT06197035

The Coping With and Caring for Infants With Special Needs Intervention in Down Syndrome Infants

Status unknown NA Last updated 1 April 2024
What this trial tests

NA trial testing Coping With and Caring for Infants With Special Needs in Down Syndrome in 40 participants. Status unknown.

Timeline
10 March 2024
Primary endpoint
20 October 2024
20 October 2024

Quick facts

Lead sponsorUniversity of Seville
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date10 March 2024
Primary completion20 October 2024
Estimated completion20 October 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Seville

Who can join

Adults 1 Month to 18 Months, any sex, with Down Syndrome or Family. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective is to compare the impact of standard infant physical therapy and the family-centered program, Coping with and Caring for Infants with Special Needs (COPCA), on infants born with Down syndrome. This is a randomized controlled trial that will be carried out in the patients' homes and outpatient settings in Spain between January 2024 and March 2024. An evaluation battery will be used that includes child and family outcomes and video analysis of therapy sessions. The Infant Motor profile will be the primary outcome instrument.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Down Syndrome

Currently open trials in the same condition.

Other University of Seville trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06197035.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing